FI920212A0 - Kemisk process. - Google Patents

Kemisk process.

Info

Publication number
FI920212A0
FI920212A0 FI920212A FI920212A FI920212A0 FI 920212 A0 FI920212 A0 FI 920212A0 FI 920212 A FI920212 A FI 920212A FI 920212 A FI920212 A FI 920212A FI 920212 A0 FI920212 A0 FI 920212A0
Authority
FI
Finland
Prior art keywords
chemical process
chemical
Prior art date
Application number
FI920212A
Other languages
English (en)
Other versions
FI920212A (fi
Inventor
Andrew Peter Thomas
Stanley Arnold Lee
David Michael Glanville Martin
Lyn Powell
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919101026A external-priority patent/GB9101026D0/en
Priority claimed from GB919106876A external-priority patent/GB9106876D0/en
Priority claimed from GB919121726A external-priority patent/GB9121726D0/en
Application filed by Ici Plc filed Critical Ici Plc
Publication of FI920212A0 publication Critical patent/FI920212A0/fi
Publication of FI920212A publication Critical patent/FI920212A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI920212A 1991-01-17 1992-01-17 Kemisk process. FI920212A (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB919101026A GB9101026D0 (en) 1991-01-17 1991-01-17 Chemical process
GB919106876A GB9106876D0 (en) 1991-04-02 1991-04-02 Manufacturing process
GB919121726A GB9121726D0 (en) 1991-10-14 1991-10-14 Process

Publications (2)

Publication Number Publication Date
FI920212A0 true FI920212A0 (fi) 1992-01-17
FI920212A FI920212A (fi) 1992-07-18

Family

ID=27265456

Family Applications (1)

Application Number Title Priority Date Filing Date
FI920212A FI920212A (fi) 1991-01-17 1992-01-17 Kemisk process.

Country Status (15)

Country Link
US (2) US5294716A (fi)
EP (1) EP0495626A1 (fi)
JP (1) JPH0559042A (fi)
KR (1) KR920014800A (fi)
AU (1) AU9012091A (fi)
CA (1) CA2058899A1 (fi)
CS (1) CS9992A3 (fi)
FI (1) FI920212A (fi)
GB (1) GB9200758D0 (fi)
HU (1) HUT60262A (fi)
IE (1) IE914572A1 (fi)
IL (1) IL100580A0 (fi)
NO (1) NO920222L (fi)
PT (1) PT100022A (fi)
ZW (1) ZW792A1 (fi)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE914572A1 (en) * 1991-01-17 1992-07-29 Zeneca Ltd Chemical process
US5591762A (en) * 1991-02-06 1997-01-07 Dr. Karl Thomae Gmbh Benzimidazoles useful as angiotensin-11 antagonists
US5602127A (en) * 1991-02-06 1997-02-11 Karl Thomae Gmbh (Alkanesultam-1-yl)-benzimidazol-1-yl)-1yl)-methyl-biphenyls useful as angiotensin-II antagonists
US5594003A (en) * 1991-02-06 1997-01-14 Dr. Karl Thomae Gmbh Tetrahydroimidazo[1,2-a]pyridin-2-yl-(benzimidazol-1-yl)-methyl-biphenyls useful as angiotensin-II antagonists
US5616599A (en) * 1991-02-21 1997-04-01 Sankyo Company, Limited Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use
US5252753A (en) * 1991-11-01 1993-10-12 Ortho Pharmaceutical Corporation Process for the preparation of certain substituted biphenyl tetrazoles and compounds thereof
SK280887B6 (sk) * 1991-11-18 2000-09-12 E. I. Du Pont De Nemours And Company Spôsob výroby tetrazolylbifenylových zlúčenín a medziprodukty tohto spôsobu
GB9201715D0 (en) * 1992-01-28 1992-03-11 Ici Plc Chemical process
HU219598B (hu) * 1992-12-17 2001-05-28 Sankyo Co. Ltd. Bifenilvegyületek imidazol- és piridinszármazékai, eljárás előállításukra és ezeket a vegyületeket tartalmazó gyógyszerkészítmények
WO2003030937A1 (fr) * 2001-10-05 2003-04-17 Ono Pharmaceutical Co., Ltd. Remedes contre des maladies liees au stress comprenant des antagonistes de recepteurs mithochondriaux de la benzodiazepine
DE60304175T2 (de) * 2002-04-29 2007-03-15 Teva Pharmaceutical Industries Ltd. Verfahren zur herstellung von losartan und losartan-kaliumsalz
CA2575177A1 (en) * 2004-09-02 2006-03-16 Teva Pharmaceutical Industries Ltd. Purification of olmesartan medoxomil
US20070054948A1 (en) * 2004-09-02 2007-03-08 Lilach Hedvati Purification of olmesartan medoxomil
CN1993355A (zh) * 2004-09-02 2007-07-04 特瓦制药工业有限公司 奥美沙坦酯的纯化方法
US20060258727A1 (en) * 2005-01-03 2006-11-16 Lilach Hedvati Olmesartan medoxomil with reduced levels of impurities
EP2527360B1 (en) 2007-06-04 2015-10-28 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
ES2522968T3 (es) 2008-06-04 2014-11-19 Synergy Pharmaceuticals Inc. Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
WO2010009319A2 (en) 2008-07-16 2010-01-21 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CA2828764A1 (en) * 2011-03-03 2012-09-07 Treventis Corporation Anti-amyloid compounds and methods
JP6151775B2 (ja) * 2012-06-25 2017-06-21 サニオナ・エイピイエス 新規のテトラゾール誘導体及びカリウムチャネルモジュレータとしてのその使用
US9708367B2 (en) 2013-03-15 2017-07-18 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
EA201592263A1 (ru) 2013-06-05 2016-05-31 Синерджи Фармасьютикалз, Инк. Ультрачистые агонисты гуанилатциклазы c, способ их получения и использования
EP3902787A4 (en) * 2018-12-28 2022-12-28 Riboscience LLC QUINAZOLINE DERIVATIVES USED AS ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 1 INHIBITORS
SG11202110888QA (en) 2019-04-12 2021-10-28 Riboscience Llc Bicyclic heteroaryl derivatives as ectonucleotide pyrophosphatase phosphodiesterase 1 inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1334092C (en) * 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
US4820843A (en) * 1987-05-22 1989-04-11 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
PL286445A1 (en) * 1989-08-11 1991-04-22 Ici Plc Method of obtaining novel quinoline derivatives
GB2244054B (en) * 1990-04-19 1994-04-06 Ici Plc Pyridine derivatives
IE914572A1 (en) * 1991-01-17 1992-07-29 Zeneca Ltd Chemical process
US5252753A (en) * 1991-11-01 1993-10-12 Ortho Pharmaceutical Corporation Process for the preparation of certain substituted biphenyl tetrazoles and compounds thereof

Also Published As

Publication number Publication date
IL100580A0 (en) 1992-09-06
PT100022A (pt) 1993-02-26
GB9200758D0 (en) 1992-03-11
AU9012091A (en) 1992-07-23
KR920014800A (ko) 1992-08-25
US5420292A (en) 1995-05-30
JPH0559042A (ja) 1993-03-09
CA2058899A1 (en) 1992-07-18
NO920222D0 (no) 1992-01-16
ZW792A1 (en) 1992-09-30
NO920222L (no) 1992-07-20
HUT60262A (en) 1992-08-28
EP0495626A1 (en) 1992-07-22
US5294716A (en) 1994-03-15
HU9200130D0 (en) 1992-04-28
CS9992A3 (en) 1992-08-12
IE914572A1 (en) 1992-07-29
FI920212A (fi) 1992-07-18

Similar Documents

Publication Publication Date Title
FI922424A0 (fi) Kemiska foereningar.
FI920212A (fi) Kemisk process.
MX22743A (es) Compuestos quimicos.
FI910817A0 (fi) Kemiskt inerta pigmentliknande zinkoxider.
FI924075A0 (fi) Elektrokemisk process.
DE69100793D1 (de) Verbessertes Hydrocyanisierungsverfahren.
DE69200894D1 (de) Reinigungsverfahren.
FI900684A0 (fi) Process foer framstaellning av polyaluminiumfoereningar.
DE69201489D1 (de) Beschichtungsverfahren.
FI901319A0 (fi) Foerbaettrade kemiska foereningar.
FI894648A (fi) Kemiska foereningar.
MX9202262A (es) Compuestos quimicos.
MX9202702A (es) Proceso de bioblanqueo.
DE59104254D1 (de) Wägeverfahren.
DE69206314D1 (de) Hydroumwandlungsverfahren.
FI932571A (fi) Kemisk process
DE69204206D1 (de) Hydrodeziklierungsverfahren.
DE69202448D1 (de) Lötverfahren.
FI922722A0 (fi) Process foer aotervinning av icke- jaernhaltiga metaller fraon pyritslagg.
ZA928450B (en) Chemical process.
MA22762A1 (fr) Procede.
MA22980A1 (fr) Procede.
NO901201D0 (no) Kjemiske forbindelser.
FI911554A0 (fi) Kemiska formulationer.
DE69024062D1 (de) Veretherungsprozess.

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: ZENECA LIMITED

FD Application lapsed